Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Author(s) -
Christian Steidl,
Tang Lee,
Sohrab P. Shah,
Pedro Farinha,
Guangming Han,
Tarun Nayar,
Allen Delaney,
Steven J.M. Jones,
Javeed Iqbal,
Dennis D. Weisenburger,
Martin Bast,
Andreas Rosenwald,
Hans-Konrad Müller-Hermelink,
Lisa M. Rimsza,
Elı́as Campo,
Jan Delabie,
Rita M. Braziel,
James R. Cook,
R. Tubbs,
Elaine S. Jaffe,
Georg Lenz,
Joseph M. Connors,
Louis M. Staudt,
Wing C. Chan,
Randy D. Gascoyne
Publication year - 2010
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0905680
Subject(s) - medicine , lymphoma , oncology , hodgkin lymphoma , disease , classical hodgkin lymphoma
Despite advances in treatments for Hodgkin's lymphoma, about 20% of patients still die from progressive disease. Current prognostic models predict the outcome of treatment with imperfect accuracy, and clinically relevant biomarkers have not been established to improve on the International Prognostic Score.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom